Panu M Jaakkola (Panu Jaakkola)

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 3

Top Topics

Renal Cell Carcinoma

Lymph Node Metastasis

Gene Expression

Top Venues

The Journal of biological chemistry

Clinical cancer research : an official journal of the American Association for Cancer Research

University of Helsinki

Turun yliopisto lääketieteellinen tiedekunta (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Helsinki Jan 01 2018

Finland

Professor :: Clinicum

Helsinki University Central Hospital Jan 01 2018

Finland

Research director :: Comprehensive cancer center

Turun yliopisto lääketieteellinen tiedekunta Jan 01 2014 - Dec 31 2017

Finland

Lecturer

Turku University Hospital May 01 2013 - Dec 31 2017

Finland

Consultant :: Oncology and radiotherapy

Education History

Turun yliopisto lääketieteellinen tiedekunta May 20 1998

Finland

PHD

Publications

Kalle E Mattila, Paula Vainio, Panu M Jaakkola
Prognostic Factors for Localized Clear Cell Renal Cell Carcinoma and Their Application in Adjuvant Therapy. Cancers 14 (1) (2022)
Reetta Virtakoivu, Jenna H Rannikko, Miro Viitala, Felix C Vaura, Akira Takeda, Tapio Lönnberg, Jussi Koivunen, Panu M Jaakkola, Annika Pasanen, Shishir Shetty, Maja J A de Jonge, Debbie G J Robbrecht, Yuk Ting Ma, Tanja Skyttä, Anna Minchom, Sirpa Jalkanen, Matti K Karvonen, Jami Mandelin, Petri Bono, Maija Hollmén
Systemic Blockade of Clever-1 Elicits Lymphocyte Activation Alongside Checkpoint Molecule Downregulation in Patients with Solid Tumors: Results from a Phase I/II Clinical Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (15) (2021)
Petra Miikkulainen, Heidi Högel, Fatemeh Seyednasrollah, Krista Rantanen, Laura L Elo, Panu M Jaakkola
Hypoxia-inducible factor (HIF)-prolyl hydroxylase 3 (PHD3) maintains high HIF2A mRNA levels in clear cell renal cell carcinoma. The Journal of biological chemistry 294 (10) (2019)